Docstoc

1239672pdf

Document Sample
1239672pdf Powered By Docstoc
					MATERIAL SAFETY DATA SHEET

PRODUCT NAME:

Furosemide Tablets

AS SOLD BY PHOENIX PHARMACEUTICAL

A Service of

DISAL (FUROSEMIDE) TABLETS

Material Safety Data Sheet
DOT HCS Risk Phrases
Not an HCS controlled material in USA.

Protective Clothing

Section 1: Product Identification and Uses
Common/Trade Name DISAL (FUROSEMIDE) TABLETS NADA #: 129-034 Not available CI# TSCA Not available TSCA inventory: No products found. Chemical name Chemical formula Chemical family Supplier Not applicable Not available Diuretic Boehringer Ingelheim Vetmedica, Inc. 2621 North Belt Hwy St. Joseph MO 64506-2002 CAS# Code Molecular weight Manufacturer Not applicable MSDS ID#: P129-034 Not applicable Boehringer Ingelheim Vetmedica, Inc. 2621 North Belt Hwy St. Joseph MO 64506-2002 816-233-2571

Synonyms

Material uses

An effective diuretic-saluretic for oral use in the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute non-inflammatory tissue edema. Use only as directed on the product label and package insert.

Section 2: Hazardous Ingredients Name CAS#
1) Furosemide: 4chloro-N-furfuryl-5sulfamoylanthranilic acid 000054319

% by Weight
12.5 & 50 mg/tablet

TLV/PEL
Not available

LC50 / LD 50
Not available

Section 3: First Aid Measures
Eye contact Skin contact Hazardous skin contact Slight inhalation Hazardous inhalation Slight ingestion Hazardous ingestion Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Seek medical attention if irritation persists. Wash contaminated skin with soap and water. Seek medical attention if irritation persists. No additional information. Allow the victim to rest in a well ventilated area. Apply artificial respiration if needed. No additional information. Not for human use. If swallowed seek medical assistance. Not available

Section 4: Physical Data
Physical state and appearance PH (1% soln/water) Solid, half-scored tablets (239 embossed on 50 mg tablet, 240 embossed on 12.5 mg tablet) Not available Odor Taste Odorless Not available

DISAL (FUROSEMIDE) TABLETS

Odor threshold Volatility Melting/Sublimation point Boiling/Condensation point Specific gravity (Water=1) Vapor density Vapor pressure Water/oil dist. Coeff. Ionicity (surface active agent) Critical temperature Instability temperature Conditions of instability Dispersion properties Solubility

Not available Not available Not available Not available Not available Not available Not available Not available Not available Not available Not available Not additional remark Not available Miscible in water

Color

White to yellowish

Section 5: Fire and Explosion Data
The product is: Auto-ignition temperature Fire degradation products Flash points Flammable limits Fire extinguishing procedures Not available Not available Not available Not available Not available SMALL FIRE: Use DRY chemicals, CO2, water spray or foam. LARGE FIRE: Use water spray, fog or foam. DO NOT use water jet. SPECIAL FIRE FIGHTING PROCEDURES: Recommend pressure-demand, self-contained breathing apparatus (SCBA). Wear full protective equipment and isolate area. Flammability Risks of explosion No specific information is available in our database regarding the flammability of this product in presence of various materials. No specific information is available in our database regarding the product’s risks of explosion in the presence of various materials.
Page 2 of 4

DISAL (FUROSEMIDE) TABLETS

Section 6: Reactivity Data
Stability Hazardous decomp. products Degradability Product of degradation Corrosivity Reactivity The product is stable. The active ingredient, furosemide, emits toxic fumes when heated to decomposition. Not available Not available No specific information is available in our database regarding the corrosivity of this product in the presence of various materials. Oxidizing and reactive materials.

Section 7: Toxicological Properties
Routes of entry TLV Toxicity for animals Ingestion, inhalation, skin contact. Not available LD50: Not available LC50: Not available Environmental hazards Not available Chronic effects on humans Carcinogenic Effects: Not carcinogenic Mutagenic Effects: Not available Teratogenic Effects: Not available Developmental Toxicity: Not available. Hypersensitivity to this and sulfonamide-like drugs. Acute effects on humans Ingestion may cause nausea, vomiting, diuresis, weakness

Section 8: Preventive Measures
Waste information Waste stream Storage Precautions Not a RCRA waste. Dispose of waste and containers in accordance with local, state and federal regulations. Not available Keep out of reach of children. Read complete package label and insert information before use. Use only as directed. Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a fume hood. Ground all equipment containing material. DO NOT breathe dust. Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on the contaminated surface and dispose of according to local and regional authority requirements. Our database contains no additional information in case of a spill and/or a leak of the product. Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the contaminated surface and allow to evacuate through the sanitary system. Gloves, safety glasses
Page 3 of 4

Small spill and leak

Large spill and leak Protective Clothing

DISAL (FUROSEMIDE) TABLETS

Section 9: Classification
DOT Not a DOT controlled material (United States).

Maritime transportation HCS Federal and State Regulations HMIS (U.S.A.)

Not available Not an HCS controlled material in USA. Not applicable

Health Hazard Fire Hazard Reactivity Personal Protection

1 0 0 B

National Fire Protection Association (U.S.A.)

1

0

Fire Hazard

0

Reactivity Specific hazard

Section 10: Protective Measures
Protective clothing Engineering controls Gloves, safety glasses Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants below the exposure limit.

Section 11: Other Information
References Not available Validated by Company: 3/22/05

CALL 1(800) 821-7467 Emergency Medical: (800)530-5432 Chemtrec: (800)424-9300
The information provided herein is offered by Boehringer Ingelheim Vetmedica, Inc. (“BIV”) in good faith as accurate as of the date hereof, but without guarantee. This information includes information which has been generated by other parties and provided to BIV, and which BIV has not independently verified. The information provided herein relates only to the specific product designated, and may not be valid where such product is used in combination with any other materials or in any process. The information provided herein is offered solely for your consideration, investigation and verification, and Boehringer Ingelheim Vetmedica, Inc. (“BIV”) expressly disclaims all liability for reliance thereon. BIV EXPRESSLY DISCLAIMS ALL WARRANTIES OF EVERY KIND AND NATURE (INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO THE USE OR SUITABILITY OF THE PRODUCT. In addition, since the conditions of use and suitability of the product for particular uses are beyond BIV’s control, ALL RISKS OF USE OF THE PRODUCT ARE THEREFORE ASSUMED BY THE USER, AND BIV EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY AS TO ANY RESULTS OBTAINED OR ARISING FROM ANY USE OF THE PRODUCT. Use or retransmission of the information contained herein in any other format than the format as presented is strictly prohibited. Nothing herein shall be construed as a permission or recommendation for the use of the product in a manner that might infringe an existing patent. BIV neither represents nor warrants that the format, content or product formulas contained in this document comply with the laws of any other country except the United States of America. © Copyright 2001 Boehringer Ingelheim Vetmedica, Inc. All rights reserved. Page 4 of 4

DISAL (FUROSEMIDE) TABLETS

The information provided herein is offered by Boehringer Ingelheim Vetmedica, Inc. (“BIV”) in good faith as accurate as of the date hereof, but without guarantee. This information includes information which has been generated by other parties and provided to BIV, and which BIV has not independently verified. The information provided herein relates only to the specific product designated, and may not be valid where such product is used in combination with any other materials or in any process. The information provided herein is offered solely for your consideration, investigation and verification, and Boehringer Ingelheim Vetmedica, Inc. (“BIV”) expressly disclaims all liability for reliance thereon. BIV EXPRESSLY DISCLAIMS ALL WARRANTIES OF EVERY KIND AND NATURE (INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO THE USE OR SUITABILITY OF THE PRODUCT. In addition, since the conditions of use and suitability of the product for particular uses are beyond BIV’s control, ALL RISKS OF USE OF THE PRODUCT ARE THEREFORE ASSUMED BY THE USER, AND BIV EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY AS TO ANY RESULTS OBTAINED OR ARISING FROM ANY USE OF THE PRODUCT. Use or re-transmission of the information contained herein in any other format than the format as presented is strictly prohibited. Nothing herein shall be construed as a permission or recommendation for the use of the product in a manner that might infringe an existing patent. BIV neither represents nor warrants that the format, content or product formulas contained in this document comply with the laws of any other country except the United States of America. © Copyright 2001 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.

Disclaimer.doc


				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:7
posted:10/28/2009
language:English
pages:7